{
    "organizations": [],
    "uuid": "e0313624dcc3dafc5da73e134dd673cf7c18e9cb",
    "author": "",
    "url": "https://www.reuters.com/article/brief-sol-gel-technologies-sees-ipo-of-5/brief-sol-gel-technologies-sees-ipo-of-5-mln-ordinary-shares-idUSFWN1PI0N3",
    "ord_in_thread": 0,
    "title": "BRIEF-Sol Gel Technologies Sees IPO Of 5 Mln Ordinary Shares",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 23, 2018 / 11:21 AM / a minute ago BRIEF-Sol Gel Technologies Sees IPO Of 5 Mln Ordinary Shares Reuters Staff 1 Min Read \nJan 23 (Reuters) - Sol Gel Technologies Ltd: \n* SOL GEL TECHNOLOGIES LTD SEES IPO OF 5.0 MILLION ORDINARY SHARES PRICED BETWEEN $11.00 AND $13.00 PER ORDINARY SHARE - SEC FILING \n* SOL GEL TECHNOLOGIES LTD SAYS INTENDS TO USE ABOUT $26.0 MILLION OF IPO PROCEEDS TO FUND PLANNED PHASE III CLINICAL TRIALS FOR TWIN FOR TREATMENT OF ACNE \n* SOL GEL TECHNOLOGIES-INTENDS TO USE ABOUT $20 MILLION OF IPO PROCEEDS TO FUND PLANNED PHASE III CLINICAL TRIALS FOR VERED FOR TREATMENT OF SUBTYPE II ROSACEA Source text : ( bit.ly/2n0Ee1C ) Further company coverage:",
    "published": "2018-01-23T13:20:00.000+02:00",
    "crawled": "2018-01-23T13:26:44.026+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "minute",
        "ago",
        "gel",
        "technology",
        "see",
        "ipo",
        "mln",
        "ordinary",
        "share",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "sol",
        "gel",
        "technology",
        "ltd",
        "sol",
        "gel",
        "technology",
        "ltd",
        "see",
        "ipo",
        "million",
        "ordinary",
        "share",
        "priced",
        "per",
        "ordinary",
        "share",
        "sec",
        "filing",
        "sol",
        "gel",
        "technology",
        "ltd",
        "say",
        "intends",
        "use",
        "million",
        "ipo",
        "proceeds",
        "fund",
        "planned",
        "phase",
        "iii",
        "clinical",
        "trial",
        "twin",
        "treatment",
        "acne",
        "sol",
        "gel",
        "use",
        "million",
        "ipo",
        "proceeds",
        "fund",
        "planned",
        "phase",
        "iii",
        "clinical",
        "trial",
        "vered",
        "treatment",
        "subtype",
        "ii",
        "rosacea",
        "source",
        "text",
        "company",
        "coverage"
    ]
}